This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Montana. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: August W. Barany: Innovator in Neurotherapeutics
Introduction
August W. Barany is a notable inventor based in Missoula, Montana, recognized for his contributions to the field of neurotherapeutics. He holds a patent that focuses on innovative compounds aimed at treating various central nervous system (CNS) diseases and disorders. His work has significant implications for the development of therapeutic agents that target norepinephrine transporters.
Latest Patents
Barany's patent, titled "1-[(2'-substituted)-piperazin-1′-yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents," encompasses racemic mixtures and enantiomerically pure forms of novel compounds. These compounds are designed to act as norepinephrine (NE) transporter (NET) inhibitor agents, which are crucial for addressing conditions such as neurodegeneration, anxiety, depression, attention deficit disorders, drug dependency, and post-traumatic stress disorder. The patent details the chemical syntheses of these compounds, which competitively bind at NET at nanomolar concentrations, demonstrating selectivity over other transporter targets and receptor binding sites.
Career Highlights
Barany is affiliated with the University of Montana, where he has been instrumental in advancing research in neurotherapeutics. His innovative approach to developing NET inhibitors has positioned him as a key figure in the field. The
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile